MYCN is a member of the MYC family of transcription factors and a potent oncogenic driver across neural crest, neuroectodermal, and neuroendocrine malignancies, including neuroblastoma, where MYCN amplification remains one of the most powerful molecular predictors of treatment failure and poor survival. MYCN has long b...
Kyabeth Torres-rodriguez, Angelle L. Brown, John M. Maris et al.· Cancer Letters· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.